Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trademark fees

This article was originally published in The Tan Sheet

Executive Summary

Filing cost will be set at $ 245 under a proposal from the U.S. Patent & Trademark Office published in the July 21 Federal Register. The proposed increase is due to an "expected funding shortfall" for the office's trademark operations in fiscal 1994. The proposal for a trademark fee increase is in accordance with HR 2632, which, if enacted, would allow the PTO commissioner to increase a trademark filing fee without regard to fluctuations in the Consumer Price Index over the last 12 months. PTO will not adjust any other fees even though its FY 1994 operating expenses are some $ 21 mil. less than planned, the notice explains. The existing fee schedule, as well as the proposed trademark adjustment, would recover $ 518.7 mil. in FY 1994 for PTO. Comments on the proposed increase are due to PTO by Aug. 20.

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS081730

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel